References
- White-Dzuro G, Gibson LE, Zazzeron L, et al. Multisystem effects of COVID-19: A concise review for practitioners. Postgrad Med. 2020. DOI:https://doi.org/10.1080/00325481.2020.1823094
- COVID-19 dermatology registry. Aad.org. cited 2020 Aug 8. Available from: https://www.aad.org/member/practice/coronavirus/registry
- COVID-19 Registry. IADVL - Indian association of dermatologists, venereologists, and leprologists. IADVL.ORG. cited 2020 Aug 8. Available from: https://www.iadvl.org/
- Giavedoni P, Podlipnik S, Pericàs JM, et al. Skin manifestations in COVID-19: prevalence and relationship with disease severity. J Clin Med. 2020;9(10):3261. Published 2020 Oct 12.
- COVID-19 | dermNet NZ. Dermnetnz.org. cited 2020 Aug 8. Available from: https://dermnetnz.org/topics/covid-19/Accessed
- Serra‐García L, Bosch‐Amate X, Alamon‐Reig F, et al. Digital ischemia triggered by coronavirus disease 2019 in a patient under cemiplimab treatment. Int J Dermatol. 2020. DOI:https://doi.org/10.1111/ijd.15239
- Paolino G, Canti V, Mercuri S, et al. Diffuse cutaneous manifestation in a new mother with COVID‐19 (SARS‐Cov‐2). Int J Dermatol. 2020;59(7):874–875.
- Malih N, Hajinasrollah G, Zare M, et al. Unexpected presentation of COVID-19 in a 38-year-old male patient: A case report. Case Rep Dermatol. 2020;12:124–131.
- Tartari F, Spadotto A, Zengarini C, et al. Herpes zoster in COVID‐19‐positive patients. Int J Dermatol. 2020;59:1028–1029.
- Bosch‐Amate X, Giavedoni P, Podlipnik S, et al. Retiform purpura as a dermatological sign of coronavirus disease 2019 (COVID‐19) coagulopathy. J Eur Acad Dermatol Venereol. 2020;34:e548–e549.
- Wang F, Nie J, Wang H, et al. Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia. J Infect Dis. 2020;221:1762–1769.
- Zhao Q, Fang X, Pang Z, et al. COVID‐19 and cutaneous manifestations: A systematic review. J Eur Acad Dermatol Venereol. 2020. Accepted Author Manuscript. DOI:https://doi.org/10.1111/jdv.16778
- Elsaie ML, Youssef EA, Nada HA. Herpes zoster might be an indicator for latent COVID 19 infection. Dermatol Ther. 2020;e13666. DOI:https://doi.org/10.1111/dth.13666